CLINICAL_TRIALS ClinicalTrials.gov record with results posted

Comparison of Bleeding Risk Between Rivaroxaban and Apixaban for the Treatment of Acute Venous Thromboembolism: The Pilot Study

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT02559856
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-09-25T00:09:50.599225+00:00
Published At: 2026-09-24T00:00:00+00:00
Record Updated At: 2026-09-24
Results Posted At: 2026-09-24
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Venous Thromboembolism"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2026-09-24"
protocolSection.identificationModule.nctId: "NCT02559856"
protocolSection.identificationModule.officialTitle: "Comparison of Bleeding Risk Between Rivaroxaban and Apixaban for the Treatment of Acute Venous Thromboembolism: The Pilot Study"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE4"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2026-09-24"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.